AU6210600A - Compositions and methods useful for the diagnosis and treatment of heparin induced thrombocytopenia/thrombosis - Google Patents

Compositions and methods useful for the diagnosis and treatment of heparin induced thrombocytopenia/thrombosis

Info

Publication number
AU6210600A
AU6210600A AU62106/00A AU6210600A AU6210600A AU 6210600 A AU6210600 A AU 6210600A AU 62106/00 A AU62106/00 A AU 62106/00A AU 6210600 A AU6210600 A AU 6210600A AU 6210600 A AU6210600 A AU 6210600A
Authority
AU
Australia
Prior art keywords
thrombosis
diagnosis
compositions
treatment
methods useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62106/00A
Inventor
Gowthami Arepally
Keiko Kamei
Shintaro Kamei
Walter Kisiel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNM Rainforest Innovations
Original Assignee
STC UNM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by STC UNM filed Critical STC UNM
Publication of AU6210600A publication Critical patent/AU6210600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU62106/00A 1999-07-13 2000-07-13 Compositions and methods useful for the diagnosis and treatment of heparin induced thrombocytopenia/thrombosis Abandoned AU6210600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14353699P 1999-07-13 1999-07-13
US60143536 1999-07-13
PCT/US2000/019000 WO2001004159A1 (en) 1999-07-13 2000-07-13 Compositions and methods useful for the diagnosis and treatment of heparin induced thrombocytopenia/thrombosis

Publications (1)

Publication Number Publication Date
AU6210600A true AU6210600A (en) 2001-01-30

Family

ID=22504494

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62106/00A Abandoned AU6210600A (en) 1999-07-13 2000-07-13 Compositions and methods useful for the diagnosis and treatment of heparin induced thrombocytopenia/thrombosis

Country Status (2)

Country Link
AU (1) AU6210600A (en)
WO (1) WO2001004159A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008086B2 (en) 1999-02-22 2011-08-30 Cora Healthcare, Inc. Protocol for monitoring direct thrombin inhibition
US7179652B2 (en) 1999-02-22 2007-02-20 Haemoscope Corporation Protocol for monitoring platelet inhibition
US7732213B2 (en) 1999-02-22 2010-06-08 Coramed Healthcare, Inc. Method of evaluating patient hemostasis
US7524670B2 (en) * 2003-08-05 2009-04-28 Haemoscope Corporation Protocol and apparatus for determining heparin-induced thrombocytopenia
EP2265948A4 (en) 2008-02-29 2011-04-20 Biomedomics Inc A rapid and sensitive method for quantitative determination of the level of heparin-pf4 complex induced immunoglobulin antibodies
WO2012101125A1 (en) * 2011-01-24 2012-08-02 INSERM (Institut National de la Santé et de la Recherche Médicale) Specific antibodies against human cxcl4 and uses thereof
ES2968371T3 (en) 2013-10-10 2024-05-09 Eastern Virginia Medical School 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as 12-lipoxygenase inhibitors
CN116731165B (en) * 2023-03-23 2024-08-13 北京巴瑞医疗器械有限公司 Anti-serotonin antibody and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466582A (en) * 1990-08-09 1995-11-14 Serbio Thrombocytopenia determination

Also Published As

Publication number Publication date
WO2001004159A1 (en) 2001-01-18

Similar Documents

Publication Publication Date Title
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
NZ514350A (en) Compositions and methods for effecting the levels of cholesterol
AU2002320456A1 (en) Removable stent and method of using the same
AU2001249881A1 (en) Method of treating the heart
HK1038691A1 (en) Antibiotic compositions for treatment of the eye
ZA966240B (en) Methods for treatment of allergic asthma.
GB9824436D0 (en) Methods of treatment
AU2103295A (en) Methods for the treatment of thrombosis
PL342076A1 (en) Method of treating surfaces
AU9016898A (en) Methods and compositions for treatment of restenosis
AU7361900A (en) Methods and compositions for the treatment and prevention of graft rejection using heat shock proteins
AU3632600A (en) Compositions and methods for the treatment of immune related diseases
ZA200003768B (en) Methods and compositions for treating diseases and conditions of the eye.
HUP0200738A3 (en) Method of the treatment of incontinence
AU6210600A (en) Compositions and methods useful for the diagnosis and treatment of heparin induced thrombocytopenia/thrombosis
AU5006499A (en) Compositions and methods for the treatment or prevention of pulmonary infections
NO20001758D0 (en) Methods and compositions for the treatment of arthritis
AU3434601A (en) Compositions and methods for the treatment of immune related diseases
AU2001264522A1 (en) Methods and compositions for the prevention of myopia
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications
IL141551A0 (en) Compositions and methods for the treatment of immune related diseases
AU4598400A (en) Method of treatment
AU1108101A (en) Method of treating plants
AU2382601A (en) Novel method of treatment
AU7606700A (en) Polyester-wax compositions and methods of making the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase